<table border="1"><tr><th>Legal form</th><td><ul><li>Incorporated</li></ul></td></tr><tr><th>ISIN</th><td><ul><li>US75886F1075</li></ul></td></tr><tr><th>Founding</th><td><ul><li>1988</li></ul></td></tr><tr><th>Seat</th><td><ul><li>Tarrytown, United States</li></ul></td></tr><tr><th>Management</th><td><ul><li>Leonard S. Schleifer, President &amp; CEO</li></ul></td></tr><tr><th>Number of employees</th><td><ul><li>8.100</li></ul></td></tr><tr><th>Sales</th><td><ul><li>5,872 billion USD</li></ul></td></tr><tr><th>Industry</th><td><ul><li>Pharmacy</li></ul></td></tr><tr><th>Website</th><td><ul><li>www.regeneron.com</li></ul></td></tr><tr><th>Regeneron Pharmaceuticals</th><td><ul><li>As of December 31, 2019</li></ul></td></tr></table>